Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
31 Oct 2024 |
AA |
Full accounts made up to 31 October 2023
|
|
|
14 Oct 2024 |
MR01 |
Registration of charge 081398260017, created on 11 October 2024
|
|
|
13 Sep 2024 |
CS01 |
Confirmation statement made on 2 September 2024 with no updates
|
|
|
06 Jun 2024 |
AP01 |
Appointment of Mr Joseph Elliott Kirk as a director on 16 May 2024
|
|
|
06 Jun 2024 |
TM01 |
Termination of appointment of James Layland as a director on 16 May 2024
|
|
|
23 May 2024 |
MR01 |
Registration of charge 081398260016, created on 23 May 2024
|
|
|
25 Apr 2024 |
MR01 |
Registration of charge 081398260015, created on 24 April 2024
|
|
|
29 Jan 2024 |
CH01 |
Director's details changed for Mr Robert John Smith on 8 January 2024
|
|
|
29 Jan 2024 |
AP01 |
Appointment of Mr Robert John Smith as a director on 8 January 2024
|
|
|
10 Jan 2024 |
MR04 |
Satisfaction of charge 081398260011 in full
|
|
|
02 Oct 2023 |
MR01 |
Registration of charge 081398260014, created on 28 September 2023
|
|
|
07 Sep 2023 |
CS01 |
Confirmation statement made on 2 September 2023 with no updates
|
|
|
29 Jun 2023 |
AA |
Full accounts made up to 31 October 2022
|
|
|
04 Nov 2022 |
TM01 |
Termination of appointment of Ian Thomas Cooper as a director on 18 October 2022
|
|
|
12 Sep 2022 |
CS01 |
Confirmation statement made on 2 September 2022 with updates
|
|
|
19 Jul 2022 |
AA |
Group of companies' accounts made up to 31 October 2021
|
|
|
25 Apr 2022 |
AP01 |
Appointment of Mr Ian Thomas Cooper as a director on 27 January 2022
|
|
|
07 Feb 2022 |
PSC05 |
Change of details for Surepharm Bidco Limited as a person with significant control on 26 January 2022
|
|
|
07 Feb 2022 |
CH01 |
Director's details changed for Mr Richard Yarwood on 26 January 2022
|
|
|
07 Feb 2022 |
CH01 |
Director's details changed for Mr James Layland on 26 January 2022
|
|
|
04 Feb 2022 |
PSC02 |
Notification of Surepharm Bidco Limited as a person with significant control on 26 January 2022
|
|
|
04 Feb 2022 |
PSC09 |
Withdrawal of a person with significant control statement on 4 February 2022
|
|
|
03 Feb 2022 |
TM01 |
Termination of appointment of Julian James Anthony Richardson as a director on 26 January 2022
|
|
|
03 Feb 2022 |
TM01 |
Termination of appointment of Julian America as a director on 26 January 2022
|
|
|
03 Feb 2022 |
AP01 |
Appointment of Mr James Layland as a director on 26 January 2022
|
|